Literature DB >> 9092530

Efficient transport and accumulation of vitamin C in HL-60 cells depleted of glutathione.

V H Guaiquil1, C M Farber, D W Golde, J C Vera.   

Abstract

Human myeloid leukemia cells (HL-60) transport only the oxidized form of vitamin C (dehydroascorbic acid) and accumulate the vitamin in the reduced form, ascorbic acid. We performed a detailed study of the role of glutathione in the intracellular trapping/accumulation of ascorbic acid in HL-60 cells. Uptake studies using HL-60 cells depleted of glutathione by treatment with L-buthionine-(S,R) sulfoximine and diethyl maleate, revealed no changes in the cells' ability to transport dehydroascorbic acid and accumulate ascorbic acid. Similar transport and accumulation rates were obtained using HL-60 cells containing intracellular glutathione concentrations from 6 mM to 1 microM. HL-60 cells, containing as little as 5 microM glutathione, were able to accumulate up to 150 mM ascorbic acid intracellularly when incubated with dehydroascorbic acid. Glutathione was capable of reducing dehydroascorbic acid by a direct chemical reaction, but only when present in a greater than 10-fold stoichiometric excess over dehydroascorbic acid. The accumulation of ascorbic acid by HL-60 cells was strongly temperature-dependent and was very inefficient at 16 degrees C. On the other hand, the direct chemical reduction of dehydroascorbic acid by excess glutathione proceeded efficiently at temperatures of 16 degrees C. Our data indicate that glutathione-dependent reductases in HL-60 cells are not responsible for the ability of these cells to accumulate millimolar concentrations of ascorbic acid. These findings indicate that alternative enzymatic mechanisms are involved in the cellular reduction of dehydroascorbic acid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092530     DOI: 10.1074/jbc.272.15.9915

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Impaired reductive regeneration of ascorbic acid in the Goto-Kakizaki diabetic rat.

Authors:  M Kashiba; J Oka; R Ichikawa; A Kageyama; T Inayama; H Kageyama; T Ishikawa; M Nishikimi; M Inoue; S Inoue
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Ascorbate enhances the toxicity of the photodynamic action of Verteporfin in HL-60 cells.

Authors:  Galina G Kramarenko; Werner W Wilke; Disha Dayal; Garry R Buettner; Freya Q Schafer
Journal:  Free Radic Biol Med       Date:  2006-01-19       Impact factor: 7.376

Review 3.  Thioredoxin reductase.

Authors:  D Mustacich; G Powis
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

4.  Ascorbate transport and recycling by SH-SY5Y neuroblastoma cells: response to glutamate toxicity.

Authors:  James M May; Liying Li; Kendra Hayslett; Zhi-chao Qu
Journal:  Neurochem Res       Date:  2006-06-22       Impact factor: 3.996

5.  Dehydroascorbic acid uptake in a human keratinocyte cell line (HaCaT) is glutathione-independent.

Authors:  I Savini; S Duflot; L Avigliano
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

6.  Assessing the reductive capacity of cells by measuring the recycling of ascorbic and lipoic acids.

Authors:  James M May
Journal:  Methods Mol Biol       Date:  2010

7.  Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.

Authors:  Mark L Heaney; Jeffrey R Gardner; Nicos Karasavvas; David W Golde; David A Scheinberg; Emily A Smith; Owen A O'Connor
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

8.  The prospects of vitamin C in cancer therapy.

Authors:  Wang-Jae Lee
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

Review 9.  Inflammation in the vascular bed: importance of vitamin C.

Authors:  Rene Aguirre; James M May
Journal:  Pharmacol Ther       Date:  2008-05-28       Impact factor: 12.310

10.  Chemical and Colloidal Dynamics of MnO2 Nanosheets in Biological Media Relevant for Nanosafety Assessment.

Authors:  Evan P Gray; Cynthia L Browning; Charles A Vaslet; Kyle D Gion; Allen Green; Muchun Liu; Agnes B Kane; Robert H Hurt
Journal:  Small       Date:  2020-03-19       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.